Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Il Clanchy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Rheumatology|March 27, 2024
TNFR2 signalling in inflammatory diseasesRichard O Williams, Felix Il Clanchy, Yi-Shu Huang, et al.
Journal of Autoimmunity|August 8, 2024
Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin toleranceFelix Il Clanchy, Federica Borghese, Jonas Bystrom, et al.
Annals of the Rheumatic Diseases|February 14, 2019
Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo <i>et al</i>Susan Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Rheumatology|March 27, 2024
TNFR2 signalling in inflammatory diseasesRichard O Williams, Felix Il Clanchy, Yi-Shu Huang, et al.
Journal of Autoimmunity|August 8, 2024
Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin toleranceFelix Il Clanchy, Federica Borghese, Jonas Bystrom, et al.
Annals of the Rheumatic Diseases|February 14, 2019
Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo <i>et al</i>Susan Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Pageof 1